NCT02687529 Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection Status COMPLETED Phase N/A
NCT02684240 A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis Status COMPLETED Phase PHASE2
NCT02681445 Non-invasive TB Triage and Patient Mapping Platform Using Breath Via Low-Cost Titanium Dioxide Nanotube Sensor Status COMPLETED Phase N/A
NCT02651259 Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women Status COMPLETED Phase PHASE1/PHASE2
NCT02627209 The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis Status UNKNOWN Phase NA
NCT02623556 Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen Status COMPLETED Phase PHASE3
NCT02619240 Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB Status COMPLETED Phase N/A
NCT02606214 A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects Status TERMINATED Phase PHASE1
NCT02605538 Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively Status WITHDRAWN Phase NA
NCT02602509 Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02583048 Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis Status COMPLETED Phase PHASE2
NCT02581579 Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection Status COMPLETED Phase NA